A Case of Amphotericin B-Resistant Cryptococcus laurentii Meningitis Complicated by Pulmonary Tuberculosis in a Patient with Pauci-Immune Crescentic Glomerulonephritis Due to MPO ANCA Vasculitis in Nepal - Scorecard - MDSpire

A Case of Amphotericin B-Resistant Cryptococcus laurentii Meningitis Complicated by Pulmonary Tuberculosis in a Patient with Pauci-Immune Crescentic Glomerulonephritis Due to MPO ANCA Vasculitis in Nepal

  • By

  • Rabin Nepali

  • Jyoti Kayastha

  • January 20, 2026

  • 0 min

Share

Clinical Scorecard: A Case of Amphotericin B-Resistant Cryptococcus laurentii Meningitis Complicated by Pulmonary Tuberculosis in a Patient with Pauci-Immune Crescentic Glomerulonephritis Due to MPO ANCA Vasculitis in Nepal

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationYoung male patients with ANCA vasculitis undergoing immunosuppressive therapy
Care Setting

Key Highlights

  • Rare case of Cryptococcus laurentii meningitis resistant to Amphotericin B in a young male
  • Co-occurrence of pulmonary tuberculosis complicating the clinical picture

Guideline-Based Recommendations

Diagnosis

    Management

    • Initiate antifungal therapy with liposomal Amphotericin B (4 mg/kg) and fluconazole (800 mg/day)
    • Adjust antifungal treatment based on susceptibility testing

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        17-year-old male with pauci-immune crescentic glomerulonephritis

        Clinical Best Practices

        • Consider prophylactic treatment for opportunistic infections in high-risk patients
        • Utilize susceptibility testing to guide antifungal therapy
        • Educate patients on signs of infection during immunosuppressive therapy
        • Recommend follow-up imaging or tests post-treatment

        Related Resources & Content

        Original Source(s)

        Related Content